欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号CZ/V/0207/001
药品名称Bultavo 3
活性成分
    • Bluetongue virus, serotype 3, strain BTV-3/NET2023, Inactivated 10320.0 ELISA unit
剂型Suspension for injection
上市许可持有人Boehringer Ingelheim
参考成员国 - 产品名称Czechia (CZ)
-
互认成员国 - 产品名称
    • Finland (FI)
    • Cyprus (CY)
    • Malta (MT)
    • Germany (DE)
    • United Kingdom (Northern Ireland) (XI)
    • Denmark (DK)
      Bultavo 3
    • Belgium (BE)
      Bultavo 3
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
      Bultavo 3
许可日期2025/03/31
最近更新日期2025/05/06
药物ATC编码
    • QI02AA08 bluetongue virus
    • QI04AA02 bluetongue virus
申请类型
  • TypeLevel1：food
  • TypeLevel2：Immunological
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase